SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-025531
Filing Date
2024-03-25
Accepted
2024-03-25 16:06:12
Documents
15
Period of Report
2024-03-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0202495-8k_fresh2.htm   iXBRL 8-K 30691
2 FORM OF SALARY CONVERSION AGREEMENT ea020249501ex10-1_fresh2.htm EX-10.1 27435
3 DEBT CONVERSION AGREEMENT, DATED MARCH 19, 2024 ea020249501ex10-2_fresh2.htm EX-10.2 27773
  Complete submission text file 0001213900-24-025531.txt   274681

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE fres-20240313.xsd EX-101.SCH 3006
5 XBRL LABEL FILE fres-20240313_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE fres-20240313_pre.xml EX-101.PRE 22353
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0202495-8k_fresh2_htm.xml XML 3568
Mailing Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108
Business Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108 1 917-397-6890
Fresh2 Group Ltd (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 8-K | Act: 34 | File No.: 001-39137 | Film No.: 24779237
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)